Cannara Biotech (CSE:LOVE, OTCQB:LOVFF), based in Montreal, Canada, is focused on the production and sale of premium cannabis and cannabis-infused products for the Canadian and international markets, today announced that Lennie Ryer, Cannara Biotech’s Chief Financial Officer, will present live at VirtualInvestorConferences.com on August 1.

DATE: Thursday, August 1
TIME: 10:30 AM – 11:00 AM ET
LINK: https://tinyurl.com/Aug1-VIC-PR


This will be a live, interactive online event where investors are invited to ask the company questions in real time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.VirtualInvestorConferences.com.

Recent Company Highlights

  • Q3 results released on July 25, reflecting a strong financial position.
  • Construction of Phase 1, 170,000 square feet, completion by end of the summer.
  • Submission of security evidence package to Health Canada in the coming weeks.
  • Cultivation license for Phase 1 expected by end of the calendar year.
  • The Company, through its subsidiary, ShopCBD.com, is launching in two weeks a U.S. hemp-based CBD online e-commerce platform, www.shopCBD.com, exclusively for the U.S. market.

About Cannara Biotech
Cannara Biotech (OTCQB: LOVFF) (CSE: LOVE) is building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in the province of Quebec. Leveraging Quebec’s low cost of electricity -the lowest in Canada, Cannara Biotech’s facility will produce and sell premium indoor grown cannabis and cannabis-infused products for the Canadian and international markets. For more information, visit our website: www.cannara.ca

About Virtual Investor ConferencesSM
Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Click here to connect with Cannara Biotech Inc. (CSE:LOVE) for an Investor Presentation.

Source: www.prnewswire.com

Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) (“Global” or the “Company”) announces it has signed a binding letter of intent (“BLOI”) on January 22, 2021 with EntheoTech Bioscience Inc. (“ET”) a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET.

EntheoTech is a Canadian bioscience company focused on the research and development of products, and protocols to promote brain health, performance optimization, and global wellness, using psychoactive substances such as psilocybin, medicinal mushrooms, and other natural products.

Keep reading... Show less

The new dispensary brings expanded access for patients along Florida’s Atlantic Coast

Trulieve Cannabis Corp. (CSE: TRUL)  (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 78th nationwide. The new 4,600 sq. ft. location marks the Company’s first in the city of Sebastian and second in Indian River county expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less